148 related articles for article (PubMed ID: 37681049)
21. Design, synthesis and biological evaluation of a new series of thiazolyl-pyrazolines as dual EGFR and HER2 inhibitors.
Sever B; Altıntop MD; Radwan MO; Özdemir A; Otsuka M; Fujita M; Ciftci HI
Eur J Med Chem; 2019 Nov; 182():111648. PubMed ID: 31493743
[TBL] [Abstract][Full Text] [Related]
22. New thieno[3,2-d]pyrimidine-based derivatives: Design, synthesis and biological evaluation as antiproliferative agents, EGFR and ARO inhibitors inducing apoptosis in breast cancer cells.
Farghaly AM; AboulWafa OM; Baghdadi HH; Abd El Razik HA; Sedra SMY; Shamaa MM
Bioorg Chem; 2021 Oct; 115():105208. PubMed ID: 34365057
[TBL] [Abstract][Full Text] [Related]
23. Some 1,3,5-trisubstituted pyrazoline derivatives targeting breast cancer: Design, synthesis, cytotoxic activity, EGFR inhibition and molecular docking.
George RF; Kandeel M; El-Ansary DY; El Kerdawy AM
Bioorg Chem; 2020 Jun; 99():103780. PubMed ID: 32224337
[TBL] [Abstract][Full Text] [Related]
24. Design and stereoselective synthesis of novel isosteviol-fused pyrazolines and pyrazoles as potential anticancer agents.
Zhu SL; Wu Y; Liu CJ; Wei CY; Tao JC; Liu HM
Eur J Med Chem; 2013 Jul; 65():70-82. PubMed ID: 23693151
[TBL] [Abstract][Full Text] [Related]
25. A Facile Synthesis and Reactions of Some Novel Pyrazole-based Heterocycles.
Abeed AAO; El-Emary TI; Youssef MSK
Curr Org Synth; 2019; 16(3):405-412. PubMed ID: 31984902
[TBL] [Abstract][Full Text] [Related]
26. New Niflumic Acid Derivatives as EGFR Inhibitors: Design, Synthesis,
Yaseen YS; Mahmood AAR; Abbas AH; Shihab WA; Tahtamouni LH
Med Chem; 2023; 19(5):445-459. PubMed ID: 36537605
[TBL] [Abstract][Full Text] [Related]
27. Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme.
El-Helby AA; Sakr H; Ayyad RRA; El-Adl K; Ali MM; Khedr F
Anticancer Agents Med Chem; 2018; 18(8):1184-1196. PubMed ID: 29651967
[TBL] [Abstract][Full Text] [Related]
28. Ru(II) carbazole thiosemicarbazone complexes with four membered chelate ring: Synthesis, molecular structures and evaluation of biological activities.
Kumar RR; Ramesh R; Małecki JG
J Photochem Photobiol B; 2016 Dec; 165():310-327. PubMed ID: 27838485
[TBL] [Abstract][Full Text] [Related]
29. Synthesis, photoluminescence properties and theoretical insights on 1,3-diphenyl-5-(9-anthryl)-2-pyrazoline and -1H-pyrazole.
Dong B; Wang M; Xu C
Luminescence; 2013; 28(5):628-33. PubMed ID: 22829359
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and biological evaluation of purine-pyrazole hybrids incorporating thiazole, thiazolidinone or rhodanine moiety as 15-LOX inhibitors endowed with anticancer and antioxidant potential.
Afifi OS; Shaaban OG; Abd El Razik HA; Shams El-Dine SEA; Ashour FA; El-Tombary AA; Abu-Serie MM
Bioorg Chem; 2019 Jun; 87():821-837. PubMed ID: 30999135
[TBL] [Abstract][Full Text] [Related]
31. Synthesis of Ni(II) complexes bearing indole-based thiosemicarbazone ligands for interaction with biomolecules and some biological applications.
Haribabu J; Jeyalakshmi K; Arun Y; Bhuvanesh NSP; Perumal PT; Karvembu R
J Biol Inorg Chem; 2017 Jun; 22(4):461-480. PubMed ID: 27995332
[TBL] [Abstract][Full Text] [Related]
32. Pyrazole Derivatives of Medically Relevant Phenolic Acids: Insight into Antioxidative and Anti-LOX Activity.
Milovanović V; Petrović ZD; Novaković S; Bogdanović GA; Simijonović D; Mladenović M; Branković J; Petrović VP
Med Chem; 2021; 17(8):807-819. PubMed ID: 32484771
[TBL] [Abstract][Full Text] [Related]
33. Synthesis, anticancer evaluation, and molecular docking studies of thiazolyl-pyrazoline derivatives.
Hosseini Nasab N; Azimian F; Shim RS; Eom YS; Shah FH; Kim SJ
Bioorg Med Chem Lett; 2023 Jan; 80():129105. PubMed ID: 36513215
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of Cytotoxic Potentials of Some Isoindole-1, 3-Dione Derivatives on HeLa, C6 and A549 Cancer Cell Lines.
Tan A; Yaglioglu AS; Kishali NH; Sahin E; Kara Y
Med Chem; 2020; 16(1):69-77. PubMed ID: 30520382
[TBL] [Abstract][Full Text] [Related]
35. Synthesis, Anticancer Activity on Prostate Cancer Cell Lines and Molecular Modeling Studies of Flurbiprofen-Thioether Derivatives as Potential Target of MetAP (Type II).
Yılmaz Ö; Bayer B; Bekçi H; Uba AI; Cumaoğlu A; Yelekçi K; Küçükgüzel ŞG
Med Chem; 2020; 16(6):735-749. PubMed ID: 31203805
[TBL] [Abstract][Full Text] [Related]
36. Discovery of New Schiff Bases Tethered Pyrazole Moiety: Design, Synthesis, Biological Evaluation, and Molecular Docking Study as Dual Targeting DHFR/DNA Gyrase Inhibitors with Immunomodulatory Activity.
Hassan AS; Askar AA; Naglah AM; Almehizia AA; Ragab A
Molecules; 2020 Jun; 25(11):. PubMed ID: 32498469
[TBL] [Abstract][Full Text] [Related]
37. A New Series of Cytotoxic Pyrazoline Derivatives as Potential Anticancer Agents that Induce Cell Cycle Arrest and Apoptosis.
Wang H; Zheng J; Xu W; Chen C; Wei D; Ni W; Pan Y
Molecules; 2017 Sep; 22(10):. PubMed ID: 28961210
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and biological evaluation of new coumarin derivatives as cytotoxic agents.
Ragab FA; Eissa AAM; Fahim SH; Salem MA; Gamal MA; Nissan YM
Arch Pharm (Weinheim); 2021 Aug; 354(8):e2100029. PubMed ID: 33872414
[TBL] [Abstract][Full Text] [Related]
39. Synthesis, biological screening and in silico studies of new N-phenyl-4-(1,3-diaryl-1H-pyrazol-4-yl)thiazol-2-amine derivatives as potential antifungal and antitubercular agents.
Nandurkar Y; Bhoye MR; Maliwal D; Pissurlenkar RRS; Chavan A; Katade S; Mhaske PC
Eur J Med Chem; 2023 Oct; 258():115548. PubMed ID: 37307623
[TBL] [Abstract][Full Text] [Related]
40. Design, Synthesis and Biological Screening of Novel 1,5-Diphenyl-3-(4-(trifluoromethyl)phenyl)-2-pyrazoline Derivatives.
Tok F; KoĂ yiÄźit-KaymakĂ Ä oÄźlu B
Acta Chim Slov; 2020 Dec; 67(4):1139-1147. PubMed ID: 33533467
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]